Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Short-term Investments: 2009-2021

Historic Short-term Investments for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to $106.5 million.

  • Avadel Pharmaceuticals' Short-term Investments fell 62.77% to $45.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $45.8 million, marking a year-over-year decrease of 62.77%. This contributed to the annual value of $106.5 million for FY2021, which is 28.84% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Short-term Investments stood at $106.5 million for FY2021, which was down 28.84% from $149.7 million recorded in FY2020.
  • In the past 5 years, Avadel Pharmaceuticals' Short-term Investments registered a high of $149.7 million during FY2020, and its lowest value of $54.4 million during FY2019.
  • For the 3-year period, Avadel Pharmaceuticals' Short-term Investments averaged around $103.5 million, with its median value being $106.5 million (2021).
  • In the last 5 years, Avadel Pharmaceuticals' Short-term Investments plummeted by 39.97% in 2019 and then spiked by 175.23% in 2020.
  • Avadel Pharmaceuticals' Short-term Investments (Yearly) stood at $77.5 million in 2017, then climbed by 16.87% to $90.6 million in 2018, then slumped by 39.97% to $54.4 million in 2019, then skyrocketed by 175.23% to $149.7 million in 2020, then fell by 28.84% to $106.5 million in 2021.